Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Infectious Disease
•
Travel and Tropical Medicine
•
Primary Care
How do you approach management of patients who develop arthritis following asymptomatic or mild chikungunya infection?
Do you commonly see development of arthritis following asymptomatic or mild chikungunya infection?
Related Questions
Do you routinely recommend doxycycline for pregnant individuals with rickettsial diseases despite the historical concern for side effects in pregnancy?
What duration of antibiotics do you use in patients with Actinomyces osteomyelitis, i.e., do you stop after 6 weeks or do you give a longer oral antibiotic course?
What factors should guide the choice between fosfomycin and nitrofurantoin for uncomplicated cystitis, given the reduced efficacy of fosfomycin?
Do you recommend starting anti-fungal prophylaxis for patients on systemic antibiotics who have a peritoneal dialysis catheter that is only currently being accessed for once weekly flushes?
What is your approach to a situation where DILI is suspected secondary to an important medication (e.g. anticoagulation, antibiotics, etc.), but the diagnosis is uncertain and the liver injury is relatively mild?
What specific clinical signs or epidemiological indicators do you prioritize for early identification of Bartonella quintana infection?
Is there any role for administering another course of recombinant zoster vaccine (Shingrix) in a previously vaccinated patient with RA, who is in clinical remission on JAK inhibitor but has had a breakthrough shingles infection?
What is your preferred method for latent tuberculosis screening prior to outpatient hemodialysis initiation for a patient with new dialysis requirements?
What duration of antibiotic therapy do you use for a loculated parapneumonic effusion that does not meet criteria for empyema?
How do you manage resistant infections that persist after stopping antibiotic therapy in patients with non-CF bronchiectasis?